DC
ELOS

Davenport & Co’s Syneron Medical Ltd ELOS Stock Holding History

Davenport & Co’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-66,700
Closed -$826K – 641
2015
Q1 		$826K Sell
66,700
-27,115
-29% -$300K 0.01% 322
2014
Q4 		$875K Sell
93,815
-23,810
-20% -$230K 0.01% 298
2014
Q3 		$1.18M Buy
117,625
+13,200
+13% +$134K 0.02% 253
2014
Q2 		$1.08M Buy
104,425
+44,675
+75% +$483K 0.02% 270
2014
Q1 		$744K Buy
59,750
+26,075
+77% +$309K 0.01% 305
2013
Q4 		$414K Buy
33,675
+558
+2% +$5.8K 0.01% 388
2013
Q3 		$285K Buy
33,117
+2,817
+9% +$24.3K 0.01% 439
2013
Q2 		$264K Buy
+30,300
New +$271K 0.01% 428

Other funds holding ELOS

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Davenport & Co's ELOS Position: Q2 2015 in Review

Davenport & Co sold out of Syneron Medical Ltd (ELOS) in Q2 2015, closing a stake of 66,700 shares — an estimated $826K sold.

Davenport & Co first reported a position in ELOS in Q2 2013 and held it in 8 quarters. The position peaked at $1.18M in Q3 2014. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2015.

  • Davenport & Co reported no remaining Syneron Medical Ltd position as of Q2 2015 after selling out during the quarter.
  • Davenport & Co sold 66,700 Syneron Medical Ltd shares in Q2 2015, an estimated $826K.
  • Davenport & Co first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 8 quarters.
  • Davenport & Co's Syneron Medical Ltd position peaked at $1.18M in Q3 2014.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2015.

Based on Davenport & Co's 13F filing for Q2 2015, filed 12 Aug 2015.